HIV seroconversion is rare if Truvada PrEP is used consistently
New integrase inhibitor bictegravir looks promising in early studies
Atripla three times weekly maintains HIV viral suppression for 24 weeks
VACS Index score can help identify HIV-positive people most at risk of neurocognitive decline
Gay and bisexual people really do have poorer mental health, national US health survey shows
Vaccination could have important role in control of UK HCV epidemic among people who inject drugs
PRO 140 antibody injections maintain viral suppression in phase 2 study
